The stock gained 10 per cent to hit upper circuit as Bombay HC ruled that the assets of the company's promoters cannot be attached under the MPID Act. The attachment followed the investigation into the Rs. 5,600 crore NSEL scam.

Dabur India on Thursday informed the Street that it has acquired the management control of Excel Investments (FZE), based in Sharjah, UAE.

Overall volumes in futures & options currently stand at 4,08,18,163 contracts with a turnover of Rs. 25,17,204.99 crore.

Overall volumes in futures & options currently stand at 4,08,18,163 contracts with a turnover of Rs. 25,17,204.99 crore.

USFDA made two observations at the facility of Granules India’s subsidiary located in Virginia. Reacting to this development, the stock of the company fell by more than 3 per cent.

The market may test the 10,450-10,500 level in the short term. On the upside, immediate resistance would be seen around the 10,810 mark. Stocks in news: Dabur, Pidilite Industries, TCS, Future Retail, Infosys.

Biocon’s Malaysia facility, which manufactures Insulin Glargine, received EU GMP Certification. Despite this development, the stock of the company fell by 0.76 per cent on Thursday.

At the time of writing, SGX Nifty was down by 7 points at 11,712 level.

The company announced the results for quarter ended June 30, 2019 wherein its net profit increased by 32.35 per cent YoY to Rs. 45.82 crore. The company also declared a final dividend of Rs. 25 per equity share.

Pidilite Speciality Chemicals Bangladesh Private Limited’s (PSCBL) manufacturing plant has been commissioned at Bhaluka in Mymensingh. This will be PSCBL’s second plant in addition to the existing plant at Munshigonj in Bangladesh.